Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 32 of 1404 for:    Peru

A Study of Acequias Contamination & Association of Infectious Diseases in Peru

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03074760
Recruitment Status : Unknown
Verified March 2017 by BioRed LLC.
Recruitment status was:  Recruiting
First Posted : March 9, 2017
Last Update Posted : March 31, 2017
Sponsor:
Information provided by (Responsible Party):
BioRed LLC

Brief Summary:
A major water supply utilized in the Lambayeque region are acequias. Acequias are irrigation canals that are utilized by the agriculture industry for the cultivation of consumables. Utilization of contaminated water to irrigate consumables can lead to foodborne illnesses. Contamination studies on the acequias in the Lambayeque region have not been performed to date. The purpose of this study is to test contamination of acequias in 9 districts in Lambayeque and determine if a difference in infection rates exists in districts with contaminated acequias vs. districts without contaminated acequias for the following diseases: H. pylori, Adenovirus, Rotavirus.

Condition or disease Intervention/treatment
Water-Related Diseases Diagnostic Test: Adenovirus Diagnostic Test: Rotavirus Diagnostic Test: H. pylori

Layout table for study information
Study Type : Observational
Estimated Enrollment : 450 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: A Study of Acequias Contamination & Association of Infectious Diseases in Peru
Actual Study Start Date : March 16, 2017
Estimated Primary Completion Date : May 1, 2017
Estimated Study Completion Date : May 1, 2017

Group/Cohort Intervention/treatment
Contaminated acequias Diagnostic Test: Adenovirus
Diagnostic test for the presence of the adenovirus in the population groups

Diagnostic Test: Rotavirus
Diagnostic test for the presence of the Rotavirus in the population groups

Diagnostic Test: H. pylori
Diagnostic test for the presence of H. pylori infection in the population groups

Non-contaminated acequias Diagnostic Test: Adenovirus
Diagnostic test for the presence of the adenovirus in the population groups

Diagnostic Test: Rotavirus
Diagnostic test for the presence of the Rotavirus in the population groups

Diagnostic Test: H. pylori
Diagnostic test for the presence of H. pylori infection in the population groups




Primary Outcome Measures :
  1. Contamination of acequias [ Time Frame: March 20th - April 1st ]
    Presence of Fecal Coliforms in the acequias


Secondary Outcome Measures :
  1. Proportion of population with infections [ Time Frame: March 20th - May 1st ]
    Proportion of populations with adenovirus, rotavirus and H. pylori infections



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
There is no study population in phase I as it is focused on the districts and their corresponding acequias. Phase II of this study will include participants 18 years of age or older who consent to participate and are from the following districts: Eten, Pomalca, Pimentel, Patapo, Pucala, Santa Rosa, Reque, Monsefu and Sana.
Criteria

Inclusion Criteria:

  • Currently reside in one of the following districts: Eten, Pomalca, Pimentel, Patapo, Pucala, Santa Rosa, Reque, Monsefu and Sana
  • 18 years of age or older
  • Consent to participate

Exclusion Criteria:

  • Currently taking antiviral or antimicrobial medication

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03074760


Contacts
Layout table for location contacts
Contact: Goode 919-672-2212 regoode0630@email.campbell.edu

Locations
Layout table for location information
Peru
BioRed Recruiting
Patapo, Lambayeque, Peru
Contact: Lozado Dominguez         
BioRed Recruiting
Pimentel, Lambayeque, Peru
Contact: Lozado Dominguez         
BioRed Recruiting
Pomalca, Lambayeque, Peru
Contact: Lozado Dominguez         
BioRed Recruiting
Pucala, Lambayeque, Peru
Contact: Lozado Dominguez         
BioRed Recruiting
Tuman, Lambayeque, Peru
Contact: Lozado Dominguez         
Sponsors and Collaborators
BioRed LLC
Investigators
Layout table for investigator information
Principal Investigator: Robert E Goode Campbell University

Layout table for additonal information
Responsible Party: BioRed LLC
ClinicalTrials.gov Identifier: NCT03074760     History of Changes
Other Study ID Numbers: CUIRBRG273
First Posted: March 9, 2017    Key Record Dates
Last Update Posted: March 31, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Communicable Diseases
Infection
Waterborne Diseases